✦ LIBER ✦

First-Line Capecitabine is as Effective as 5-Fluorouracil/Leucovorin in Treating Advanced Colorectal Cancer

✍ Scribed by B. Diane Gambill

Book ID: 119616981
Publisher: CIG Media Group, LP.
Year: 2001
Tongue: English
Weight: 94 KB
Volume: 1
Category: Article
ISSN: 1533-0028
DOI: 10.1016/s1533-0028(11)70533-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Recommendation for Irinotecan, 5-Fluorou

Recommendation for Irinotecan, 5-Fluorouracil, and Leucovorin as First-Line Therapy for Colorectal Cancer

✍ Maxine D. Fisher; Leonard Saltz; Richard Goldberg; Richard Schilsky 📂 Article 📅 2001 🏛 CIG Media Group, LP. 🌐 English ⚖ 92 KB

Capecitabine plus oxaliplatin (XELOX) ve

Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/leucovorin plus oxaliplatin (FOLFOX-6) as first-line treatment for metastatic colorectal cancer

✍ Michel Ducreux; Jaafar Bennouna; Mohamed Hebbar; Marc Ychou; Gérard Lledo; Thier 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 440 KB

## Abstract A regimen consisting of 5‐fluorouracil/leucovorin plus oxaliplatin (FOLFOX‐6) is widely used in France in the first‐line treatment of metastatic colorectal cancer (MCRC). The aim of our study was to demonstrate the non‐inferiority of capecitabine plus oxaliplatin (XELOX) __versus__ FOLF

Pharmacogenetic approach for capecitabin

Pharmacogenetic approach for capecitabine or 5-fluorouracil selection to be combined with oxaliplatin as first-line chemotherapy in advanced colorectal cancer

✍ Eva Martinez-Balibrea; Albert Abad; Enrique Aranda; Javier Sastre; Jose Luis Man 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 249 KB

6592 POSTER 5-Fluorouracil/Leucovorin, O

6592 POSTER 5-Fluorouracil/Leucovorin, Oxaliplatin and Irinotecan (FOLFOXIRI) as First-Line Treatment of Advanced Gastric Cancer

✍ Grande, C.; Martinez, M.; Villanueva, M.J.; Huidobro, G.; Casal, J. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Activity and Safety of Oxaliplatin with

Activity and Safety of Oxaliplatin with Weekly 5-Fluorouracil Bolus and Low-Dose Leucovorin as First-Line Treatment for Advanced Colorectal Cancer

✍ Javier Cassinello; Pilar Escudero; Antonieta Salud; Fernando Marcos; Eduardo Puj 📂 Article 📅 2003 🏛 CIG Media Group, LP. 🌐 English ⚖ 103 KB

Phase III trial of 5-fluorouracil (5FU)

Phase III trial of 5-fluorouracil (5FU) and leucovorin (LV) with or without trimetrexate (TMTX) as first line treatment in advanced colorectal cancer (ACC)

✍ C.J.A. Punt; H.J. Keizer; J. Douma; J. Schüller; T. Skovsgaard; C.H.H. ten Napel 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 117 KB